Mismatch repair deficient hematopoietic stem cells are preleukemic stem cells.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28767666)

Published in PLoS One on August 02, 2017

Authors

Yulan Qing1, Stanton L Gerson1

Author Affiliations

1: Case Comprehensive Cancer Center, National Center for Regenerative Medicine, Case Western Reserve University, Cleveland, Ohio, United States of America.

Articles cited by this

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 32.63

A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature (2000) 16.75

The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell (1993) 13.54

Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell (1997) 12.60

Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature (1994) 8.04

Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature (2014) 6.83

The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol (2006) 6.16

Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell (1995) 5.54

Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med (1996) 4.87

Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol (2006) 4.32

Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci Transl Med (2012) 4.05

AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci U S A (2000) 3.68

Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol (2008) 3.57

Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res (2002) 3.39

Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc Natl Acad Sci U S A (2014) 3.39

Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet (2001) 3.15

Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol (2006) 3.00

Mechanisms of stem cell self-renewal. Annu Rev Cell Dev Biol (2009) 3.00

AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc Natl Acad Sci U S A (2001) 2.84

MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet (1995) 2.49

Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J (1996) 2.11

Thymic microenvironments for T cell differentiation and selection. Nat Immunol (2006) 1.96

Genomic instability of microsatellite repeats and its association with the evolution of chronic myelogenous leukemia. Blood (1994) 1.72

The landscape of microsatellite instability in colorectal and endometrial cancer genomes. Cell (2013) 1.68

Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res (1999) 1.62

Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome. Am J Hum Genet (2004) 1.58

Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol (1998) 1.55

Neurofibromatosis and early onset of cancers in hMLH1-deficient children. Cancer Res (1999) 1.50

Influence of thymectomy, splenectomy, and gonadectomy on incidence of radiation-induced lymphoid tumors in strain C57 black mice. J Natl Cancer Inst (1950) 1.46

Conditional inactivation of MLH1 in thymic and naive T-cells in mice leads to a limited incidence of lymphoblastic T-cell lymphomas. Leuk Lymphoma (2010) 1.45

Repopulating defect of mismatch repair-deficient hematopoietic stem cells. Blood (2003) 1.44

AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML. Oncogene (2001) 1.42

Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells. Nat Med (2011) 1.34

Mutator phenotype in Msh2-deficient murine embryonic fibroblasts. Cancer Res (1997) 1.31

Flow cytometry analysis of murine hematopoietic stem cells. Cytometry A (2012) 1.29

Microsatellite instability of selective target genes in HNPCC-associated colon adenomas. Oncogene (2005) 1.26

A homozygous germ-line mutation in the human MSH2 gene predisposes to hematological malignancy and multiple café-au-lait spots. Cancer Res (2002) 1.23

Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia. Blood (1999) 1.18

The role of DNA repair in somatic hypermutation of immunoglobulin genes. J Exp Med (1998) 1.09

Spontaneous and induced preleukemia cells in C57BL/6 mice:brief communication. J Natl Cancer Inst (1978) 1.07

Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL). Blood (1997) 1.03

Early onset brain tumor and lymphoma in MSH2-deficient children. Am J Hum Genet (2003) 0.96

TGF-beta type II receptor-deficient thymocytes develop normally but demonstrate increased CD8+ proliferation in vivo. Blood (2005) 0.94

A lack of DNA mismatch repair on an athymic murine background predisposes to hematologic malignancy. Cancer Res (2005) 0.89

Development of lymphoma in the thymus of AKR mice treated with the lymphomagenic virus SL 3-3. Cancer Res (1989) 0.89

Tumors of DNA mismatch repair-deficient hosts exhibit dramatic increases in genomic instability. Proc Natl Acad Sci U S A (1998) 0.87

Genetic instability of microsatellites in hematological neoplasms. Leukemia (1995) 0.86

Marrow-thymus interactions during radiation leukemogenesis in C57BL/Ka mice. Cancer Res (1981) 0.86

Azathioprine-induced carcinogenesis in mice according to Msh2 genotype. J Natl Cancer Inst (2010) 0.85

Non-Hodgkin's lymphoma in a patient with probable hereditary nonpolyposis colon cancer: report of a case and review of the literature. Dis Colon Rectum (2002) 0.84

Thymic lymphomas arising in Msh2 deficient mice display a large increase in mutation frequency and an altered mutational spectrum. Mutat Res (2002) 0.83

Tumors arising in DNA mismatch repair-deficient mice show a wide variation in mutation frequency as assessed by a transgenic reporter gene. Carcinogenesis (2000) 0.82

MSH2-deficient murine lymphomas harbor insertion/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency microsatellite instability. Blood (2000) 0.82

Enhanced AKR leukemogenesis by the dual tropic viruses. I. The time and site of origin of potential leukemic cells. Leukemia (1987) 0.81

Development of virus-accelerated thymic lymphoma in AKR mice. J Natl Cancer Inst (1985) 0.80

Prolongation of life with prevention of leukemia by thymectomy in mice. J Gerontol (1946) 0.76

Association of a duodenal follicular lymphoma and hereditary nonpolyposis colorectal cancer. Mod Pathol (2000) 0.76

Missing mismatch repair: a key to T cell immortality. Leuk Lymphoma (2010) 0.75